Skip to NavigationSkip to content

News

Gilead's Biktarvy has been awarded marketing authorisation in the European Union from the European Commission for the treatment of HIV-1 infection.
Sophiris has revealed that a patient death had prompted it to put the brakes on its Phase 2b investigation into the efficacy of its pore-forming...
Eli Lilly has announced new data on Trulicity and investigational 3.0 and 4.5mg doses of dulaglutide, revealing that all three provided “...
Johnson & Johnson’s Group Worldwide Chairman Sandra Peterson has announced she is to retire from her role and the company effective 1 October...
Roche has unveiled new data on the efficacy of Tecentriq in combination with chemotherapy for the treatment of previously untreated extensive-stage...
CRUK warns cancer prevalence in UK elderly is set to almost double by 2035, and report suggests NHS could save up to £7 billion through new...
NICE has recommended dupilumab, in combination with topical corticosteroids, for use on the NHS in England for the treatment of moderate to severe...
The US Food and Drug Administration (FDA) has approved the Eversense Continuous Glucose Monitoring (CGM) system for use in people  aged over...
In a big step forward for India as AstraZeneca announces that its checkpoint inhibitor Imfinzi has secured approval in the country from the DCGI to...
Roche and multiple sclerosis (MS) patients across England and Wales are celebrating the news that healthcare watchdog NICE has recommended the use...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches